AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (January 9, 2007). doi:10.1152/ajprenal.00339.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/F1626    most recent
00339.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (41)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tögel, F.
Right arrow Articles by Westenfelder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tögel, F.
Right arrow Articles by Westenfelder, C.
Submitted on August 29, 2006
Accepted on January 2, 2007

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury

Florian Tögel1, Kathleen Weiss2, Ying Yang3, Zhuma Hu2, Ping Zhang2, and Christof Westenfelder4*

1 Medicine/ Division ofNephrology, University of Utah, Salt lake City, Utah, United States
2 Medicine/Nephrology, University of Utah, Salt Lake City, United States
3 Medicine/Nephrology, University of Utah, Salt Lake City, Utah, United States
4 Division of Nephrology, VA Medical Center, Univ of Utah, 500 Foothill Blvd., Salt Lake City, Utah, 84148, United States; Medicine/ Division ofNephrology, University of Utah, Salt Lake City, United States; Physiology, University of Utah, Salt Lake City, United States

* To whom correspondence should be addressed. E-mail: c.westenfelder{at}uofu.net.

Acute kidney injury (AKI) is a major clinical problem in which a critical vascular, pathophysiological component is recognized. We demonstrated previously that mesenchymal stem cells (MSC) unlike fibroblasts are significantly renoprotective after ischemia/reperfusion injury, and concluded that this renoprotection is mediated primarily by paracrine mechanisms. In this study we investigated whether MSCs possess vasculo-protective activity that may contribute, at least in part, to improved outcome after ischemia/reperfusion AKI. MSC conditioned medium contains VEGF, HGF and IGF-1, and augments aortic endothelial cell (EC) growth and survival, a response not observed with fibroblast conditioned medium. MSC and EC share vasculotropic gene expression profiles, both form capillary tubes in vitro on matrigel alone or in cooperation without fusion. MSC undergo differentiation into an endothelial-like cell phenotype in culture and develop into vascular structures in vivo. Infused MSC were readily detected in the kidney early after reflow but were only rarely engrafted at one week post AKI. MSC attached in the renal microvascular circulation significantly decreased apoptosis of adjacent cells. Infusion of MSC immediately after reflow in severe ischemia/reperfusion AKI did not improve renal blood flow, renovascular resistance or outer cortical blood flow. These data demonstrate that the unique vasculotropic, paracrine actions elicited by MSC play a significant renoprotective role after AKI, further demonstrating that cell therapy has promise as a novel intervention in AKI.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
C Bocelli-Tyndall, L Bracci, S Schaeren, C Feder-Mengus, A Barbero, A Tyndall, and G C Spagnoli
Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15
Ann Rheum Dis, August 1, 2009; 68(8): 1352 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. H. Bahlmann and D. Fliser
The plasticity of progenitor cells--why is it of interest to the nephrologists?
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2018 - 2020.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. Bi, J. Guo, A. Marlier, S. R. Lin, and L. G. Cantley
Erythropoietin expands a stromal cell population that can mediate renoprotection
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1017 - F1022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Curtis, S. Chen, B. Chen, A. Agarwal, C. A. Klug, and P. W. Sanders
Contribution of intrarenal cells to cellular repair after acute kidney injury: subcapsular implantation technique
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F310 - F314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Togel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F315 - F321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Schmitt and L. G. Cantley
The impact of aging on kidney repair
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1265 - F1272.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Li, P. Truong, P. Igarashi, and F. Lin
Renal and Bone Marrow Cells Fuse after Renal Ischemic Injury
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3067 - 3077.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Imberti, M. Morigi, S. Tomasoni, C. Rota, D. Corna, L. Longaretti, D. Rottoli, F. Valsecchi, A. Benigni, J. Wang, et al.
Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2921 - 2928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.